Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19.  Figgatt MC, Salazar Z, Day E, Vincent L, Dasgupta N.  J Subst Abuse Treat. 2021 Apr;123:108276. doi: 10.1016/j.jsat.2021.108276. Epub…

Designing and Evaluating COVID-19 Protocols for an Office-Based Opioid Treatment Program in an Urban Underserved Setting.  O'Gurek DT.  J Am Board Fam Med. 2021 Feb;34(Suppl):S136-S140. doi: 10.3122/jabfm.2021.S1.200207. PMID: 33622828…

Helping People Who Are Homeless Stay Healthy During the Pandemic.  Rubin R.  JAMA. 2021 Feb 9;325(6):517-519. doi: 10.1001/jama.2020.23436. PMID: 33471026. https://jamanetwork.com/journals/jama/fullarticle/2775588

COVID-19 Adaptations in the Care of Patients with Opioid Use Disorder: a Survey of California Primary Care Clinics.  Caton L, Cheng H, Garneau HC, Fisher T, Harris-Mills B, Hurley B, Newman S, McGovern MP. J Gen Intern Med. 2021 Jan 28:1–8. do…

Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders.  Becker SJ, Garner BR, Hartzler BJ.  J Subst Abuse Treat. 2021 Mar;122:108210. doi: 10.1016/j.jsat.202…

Telehealth sustains patient engagement in OUD treatment during COVID-19.  Langabeer JR 2nd, Yatsco A, Champagne-Langabeer T.  J Subst Abuse Treat. 2021 Mar;122:108215. doi: 10.1016/j.jsat.2020.108215. Epub 2020 Nov 24. PMID: 33248863; PM…